Verve Therapeutics, Inc. (VERV) - Quarterly Income Statement

Home
VERV
Financials

11.28 (USD) • At close July 1, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	32.976	13.08	6.865	6.692	5.695	5.144	3.117	2.093	1.404	1.012	0.929	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	32.976	13.08	6.865	6.692	5.695	5.144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0.87	0.745	0.751	0.713	0.705	-0.026	-0.446	-0.965	-1.523	-1.15	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	54.458	55.048	49.938	50.984	48.376	46.811	43.765	47.26	47.11	37.284	35.197	33.125	24.49	25.939	17.495	13.423	11.345	15.576	7.618	5.654	6.523
General & Administrative Expenses Numbers are in millions	15.154	14.099	13.837	14.547	14.163	12.281	11.686	13.416	12.553	11.438	9.592	9.067	7.435	6.601	6.007	3.541	2.716	2.024	1.354	1.032	0.846
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	15.154	14.099	13.837	14.547	14.163	12.281	11.686	13.416	12.553	11.438	9.592	9.067	7.435	6.601	6.007	3.541	2.716	2.024	1.354	1.032	0.846
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0.738	2.177	-3.306	0.938	1.677	1.139	0.7	-36.006	0.778	-5.929	-0.055	-0.944	1.689
Operating Expenses Numbers are in millions	69.612	69.147	63.775	65.531	62.539	59.092	55.451	60.676	59.663	48.722	44.789	42.192	31.925	32.54	23.502	16.964	14.061	17.6	8.972	6.686	7.369
Operating Income Numbers are in millions	-36.636	-56.067	-56.91	-58.839	-56.844	-53.948	-52.334	-58.583	-58.259	-47.71	-43.86	-42.192	-31.925	-32.54	-23.502	-16.964	-14.061	-17.6	-8.972	-6.686	-7.369
Operating Income Ratio Numbers are in millions	-1.111	-4.286	-8.29	-8.792	-9.981	-10.488	-16.79	-27.99	-41.495	-47.144	-47.212	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	5.682	6.105	6.881	9.1	8.214	5.628	6.643	4.776	6.284	6.678	-1.33	1.246	1.759	1.203	0.753	-36.001	0.798	-5.931	-0.018	-0.894	1.766
Income Before Tax Numbers are in millions	-30.954	-49.962	-50.029	-49.739	-48.63	-48.32	-45.691	-53.807	-51.975	-41.032	-45.19	-40.946	-30.166	-31.337	-22.749	-52.965	-13.263	-23.531	-8.99	-7.58	-5.603
Income Before Tax Ratio Numbers are in millions	-0.939	-3.82	-7.288	-7.433	-8.539	-9.393	-14.659	-25.708	-37.019	-40.545	-48.644	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0.079	0.073	0.104	0.066	0.106	0.032	0.067	0.176	-6.284	0.053	1.33	-1.246	-1.759	-1.203	-0.753	36.001	-0.798	5.933	0.018	0.894	-1.766
Net Income Numbers are in millions	-31.033	-50.035	-50.133	-49.805	-48.736	-48.352	-45.758	-53.983	-45.691	-41.085	-46.52	-39.7	-28.407	-31.337	-22.749	-52.965	-13.263	-23.531	-8.99	-7.58	-5.603
Net Income Ratio Numbers are in millions	-0.941	-3.825	-7.303	-7.442	-8.558	-9.4	-14.68	-25.792	-32.543	-40.598	-50.075	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.35	-0.58	-0.59	-0.59	-0.59	-0.69	-0.72	-0.87	-0.74	-0.67	-0.81	-0.82	-0.58	-0.65	-0.47	-1.1	-0.3	-0.81	-0.31	-0.26	-0.19
EPS Diluted Numbers are in millions	-0.35	-0.58	-0.59	-0.59	-0.59	-0.69	-0.72	-0.87	-0.74	-0.67	-0.81	-0.82	-0.58	-0.65	-0.47	-1.1	-0.3	-0.81	-0.31	-0.26	-0.19
EBITDA Numbers are in millions	-34.92	-54.367	-55.156	-57.172	-55.212	-52.431	-50.86	-57.246	-57.132	-46.785	-43.143	-41.544	-31.411	-32.068	-23.09	-16.607	-13.767	-17.347	-8.348	-6.4	-7.204
EBITDA Ratio Numbers are in millions	-1.111	-4.156	-8.034	-8.543	-9.695	-10.193	-16.317	-27.351	-40.692	-46.23	-46.44	0	0	0	0	0	0	0	0	0	0

Verve Therapeutics, Inc.

NASDAQ:VERV Add to watchlist

NASDAQ:VERV